Buscar resultados de ensayos clínicos
Paraneoplastic Syndromes - 51 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) Condición: Lambert Eaton Myasthenic Syndrome Fecha: 2011-06-17 Intervenciones:
|
No longer available |
Nombre del estudio: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome Condición: Lambert-Eaton Myasthenic Syndrome Fecha: 2011-06-13 Intervenciones: Drug: 3,4 DAP Recommended maximum dosage: 20mg four times daily and if needed an additional 20 mg per da |
Completed |
Nombre del estudio: MC-5A for Chemotherapy Induced Peripheral Neuropathy Condición: Neuropathy, Paraneoplastic Fecha: 2010-12-09 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Condición: Congenital Myasthenic Syndrome Fecha: 2010-09-15 Intervenciones: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Available |
Nombre del estudio: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine Condición: Lambert-Eaton Myasthenic Syndrome Fecha: 2009-10-08 Intervenciones: Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses |
Recruiting |
Nombre del estudio: The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes Condición: Paraneoplastic Syndromes Fecha: 2006-05-17 |
Active, not recruiting |
Nombre del estudio: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China Condición: Anti-NMDA Receptor Enphalitis Fecha: 2015-09-23 |
Active, not recruiting |
Nombre del estudio: Ephedrine for the Treatment of Congenital Myasthenia Condición: Myasthenic Syndromes, Congenital Fecha: 2007-10-07 Intervenciones: Drug: Ephedrine |
Available |
Nombre del estudio: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condición:
Fecha: 2017-02-21 Intervenciones: Drug: 3,4-Diaminopyridine The investigator will prescribe an initial dose of 3,4 diaminopyridine (DAP) b |
Recruiting |
Nombre del estudio: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) Condición: Lambert-Eaton Myasthenic Syndrome Fecha: 2016-11-16 Intervenciones:
|